Rona M Smith

Summary

Country: UK

Publications

  1. pmc Progress in treatment of ANCA-associated vasculitis
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB20QQ, UK
    Arthritis Res Ther 14:210. 2012
  2. doi Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
    Rona M Smith
    Addenbrooke s Hospital, Cambridge, UK
    Arthritis Rheum 64:3760-9. 2012
  3. doi Biological therapy for lupus nephritis-tribulations and trials
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, UK
    Nat Rev Rheumatol 6:547-52. 2010

Detail Information

Publications3

  1. pmc Progress in treatment of ANCA-associated vasculitis
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB20QQ, UK
    Arthritis Res Ther 14:210. 2012
    ..As rare diseases, treatment advances in vasculitis depend on international collaborative research networks both to establish an evidence base for newer agents and to develop recommendations for patient management...
  2. doi Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
    Rona M Smith
    Addenbrooke s Hospital, Cambridge, UK
    Arthritis Rheum 64:3760-9. 2012
    ..However, further relapse is common, and maintenance strategies are required. The aim of this study was to reduce relapse rates using a fixed-interval rituximab re-treatment protocol...
  3. doi Biological therapy for lupus nephritis-tribulations and trials
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, UK
    Nat Rev Rheumatol 6:547-52. 2010
    ..The complexities of clinical trials in lupus nephritis have impeded the demonstration of the efficacy of new agents, but if these difficulties can be overcome, there is a real chance that outcomes in lupus nephritis will improve...